Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Stagg

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
International Journal of Cancer|August 29, 2013
Anti-CD73 therapy impairs tumor angiogenesisBertrand Allard, Martin Turcotte, Kathleen Spring, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell densityRaphaëlle Romieu-Mourez, Moïra François, Marie-Noëlle Boivin, et al.
Nanotechnology|February 4, 2021
Ablation of cells in mice using antibody-functionalized multiwalled carbon nanotubes (Ab-MWCNTs) in combination with microwavesAmy Chall, John Stagg, Andrew Mixson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2015
CD73 plays a protective role in collagen-induced arthritisPavel Chrobak, Roxanne Charlebois, Pavel Rejtar, et al.
Oncoimmunology|February 28, 2014
A<sub>2A</sub> blockade enhances anti-metastatic immune responsesPaul A Beavis, Nicole Milenkovski, John Stagg, et al.
Oncoimmunology|August 16, 2019
Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasisBertrand Allard, Isabelle Cousineau, David Allard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2015
CD73 Expression Is an Independent Prognostic Factor in Prostate CancerBruno G Leclerc, Roxanne Charlebois, Guillaume Chouinard, et al.
Elife|June 1, 2023
The CD73 immune checkpoint promotes tumor cell metabolic fitnessDavid Allard, Isabelle Cousineau, Eric H Ma, et al.
Leukemia|April 10, 2020
Targeting an adenosine-mediated "don't eat me signal" augments anti-lymphoma immunity by anti-CD20 monoclonal antibodyKyohei Nakamura, Mika Casey, Harald Oey, et al.
Cancer Research|November 23, 2016
PolyI:C and CpG Synergize with Anti-ErbB2 mAb for Treatment of Breast Tumors Resistant to Immune Checkpoint InhibitorsRoxanne Charlebois, Bertrand Allard, David Allard, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
International Journal of Cancer|August 29, 2013
Anti-CD73 therapy impairs tumor angiogenesisBertrand Allard, Martin Turcotte, Kathleen Spring, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell densityRaphaëlle Romieu-Mourez, Moïra François, Marie-Noëlle Boivin, et al.
Nanotechnology|February 4, 2021
Ablation of cells in mice using antibody-functionalized multiwalled carbon nanotubes (Ab-MWCNTs) in combination with microwavesAmy Chall, John Stagg, Andrew Mixson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2015
CD73 plays a protective role in collagen-induced arthritisPavel Chrobak, Roxanne Charlebois, Pavel Rejtar, et al.
Oncoimmunology|February 28, 2014
A<sub>2A</sub> blockade enhances anti-metastatic immune responsesPaul A Beavis, Nicole Milenkovski, John Stagg, et al.
Oncoimmunology|August 16, 2019
Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasisBertrand Allard, Isabelle Cousineau, David Allard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2015
CD73 Expression Is an Independent Prognostic Factor in Prostate CancerBruno G Leclerc, Roxanne Charlebois, Guillaume Chouinard, et al.
Elife|June 1, 2023
The CD73 immune checkpoint promotes tumor cell metabolic fitnessDavid Allard, Isabelle Cousineau, Eric H Ma, et al.
Leukemia|April 10, 2020
Targeting an adenosine-mediated "don't eat me signal" augments anti-lymphoma immunity by anti-CD20 monoclonal antibodyKyohei Nakamura, Mika Casey, Harald Oey, et al.
Cancer Research|November 23, 2016
PolyI:C and CpG Synergize with Anti-ErbB2 mAb for Treatment of Breast Tumors Resistant to Immune Checkpoint InhibitorsRoxanne Charlebois, Bertrand Allard, David Allard, et al.
Pageof 11